LKM512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis

Clinical and Experimental Allergy

Volumn 37, Issue 3, 2007, Pages 358-370

  Matsumoto, M ^a,b   Aranami, A ^c,d   Ishige, A ^d   Watanabe, K ^d   Benno, Y ^b  

^a Nishitama gun   (Japan)

^b RIKEN BIORESOURCE CENTER   (Japan)

^c Aranami Clinic   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; Intestinal microbiota; Polyamine; Pro biotics; Terminal restriction fragment length polymorphism

Indexed keywords

BUTYRIC ACID; CYTOKINE; GAMMA INTERFERON; LKM 512; PLACEBO; POLYAMINE; SHORT CHAIN FATTY ACID; SPERMIDINE; UNCLASSIFIED DRUG; YOGHURT;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG USE; DYNAMICS; FECES MICROFLORA; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; INTERVENTION STUDY; INTESTINE FUNCTION; MALE; MICROBIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPECIES; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADULT; BIFIDOBACTERIUM; CROSS-OVER STUDIES; CYTOKINES; DERMATITIS, ATOPIC; DIGESTIVE SYSTEM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PROBIOTICS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; YOGURT;

EID: 33847795377     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02642.x     Document Type: Article

References (57)

1. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29:342-6.
2. Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. Aberrant composition of gut microbiota of allergic infant: a target of bifidobacterial therapy at weaning? Gut 2002; 51:51-5.
3. Gronlunda M-M, Arvilommic H, Keroa P, Lehtonenb O-P, Isolauria E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child Fetal Neonatal Ed 2000; 83:F186-92.
4. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129-34.
5. Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, Isolauri E. Characterizing the composition of intestinal micro-flora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001; 32:1-7.
6. Ikezawa Z. Basic and clinical aspects of adult atopic dermatitis. (in Japanese with English summary). Biotherapy 1999; 13:961-9.
7. Matsumoto M, Ohishi H, Kakizoe K, Benno Y. Faecal microbiota and secretory immunoglobulin a levels in adult patients with atopic dermatitis. Microbial Ecol Health Dis 2004; 16:13-7.
8. Matsumoto M. Intestinal bacterial metabolites and host's health. Jpn J Bacteriol 2005; 60:459-67 (in Japanese).
9. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30:1604-10.
10. Pohjavuori E, Viljanen M, Korpela R et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol 2004; 114:131-6.
11. Shimada T, Cheng L, Enomoto T, Yang X, Miyoshi A, Shirakawa T. Lysed Enterococcus faecalis FK-23 oral administration reveals inverse association between tuberculin responses and clinical manifestations in perennial allergic rhinitis: a pilot study. J Invest Allergol Clin Immunol 2004; 14:187-92.
12. Rosenfeldt V, Benfeldt E, Nielsen SD et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111:389-95.
13. Aldinucci C, Bellussi L, Monciatti G et al. Effects of dietary yoghurt on immunological and clinical parameters of rhinopathic patients. Eur J Clin Nutr 2002; 56:1155-61.
14. Hayashi H, Sakamoto M, Benno Y. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 2002; 46:535-48.
15. Suau A, Bonnet R, Sutren M et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999; 65:4799-807.
16. Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic Interleukin-12 (IL-12) while Gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 2000; 68:3581-6.
17. Kimoto H, Mizumachi K, Okamoto T, Kurisaki J. New Lactococcus strain with immunomodulatory activity: enhancement of Th1-type immune response. Microbiol Immunol 2004; 48:75-82.
18. Ukabam SO, Mann RJ, Cooper BT. Small intestinal permeability to sugars in patients with atopic eczema. Br J Dermatol 1984; 110:649-52.
19. Dupont C, Barau E, Molkhou P, Raynaud F, Barbet JP, Dehennin L. Food-induced alterations of intestinal permeability in children with cow's milk-sensitive enteropathy and atopic dermatitis. J Pediatr Gastroenterol Nutr 1989; 8:459-65.
20. Majamaa H, Isolauri E. Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J Allergy Clin Immunol 1996; 97:985-90.
21. Wold AE. The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora? Allergy 1998; 53:20-5.
22. Dufour C, Dandrifosse G, Forget P, Vermesse F, Romain N, Lepoint A. Spermine and spermidine induce intestinal maturation in the rat. Gastroenterology 1988; 95:112-6.
23. Wang J-Y, McCormack S, Viar M-J, Johnson L. Stimulation of proximal small intestinal mucosal growth by luminal polyamines. Am J Physiol 1991; 261:G504-11.
24. Buts J-P, de Ketser N, Kolanowski J, Spkal E, van Hoof F. Maturation of villus and crypt cell functions in rat small intestine. Role of dietary polyamines. Dig Dis Sci 1993; 38:1091-8.
25. Deloyer P, Peulen O, Dandrifosse G. Dietary polyamines and nonneoplastic growth and disease. Eur J Gastroenterol Hepatol 2001; 13:1027-32.
26. Kanauchi O, Iwanaga T, Mitsuyama K et al. Butyrate from bacterial fermentation of germinated barley foodstuff preserves intestinal barrier function in experimental colitis in the rat model. J Gastroenterol Hepatol 1999; 14:880-8.
27. Mariadason JM, Barkla DH, Gibson PR. Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. Am J Physiol 1997; 272:G705-12.
28. Venkatraman A, Ramakrishna BS, Pulimood AB. Butyrate hastens restoration of barrier function after thermal and detergent injury to rat distal colon in vitro. Scand J Gastroenterol 1999; 34:1087-92.
29. Matsumoto M, Ohishi H, Benno Y. H1-ATPase activity in Bifidobacterium with special reference to acid tolerance. Int J Food Microbiol 2004; 93:109-13.
30. Matsumoto M, Tani H, Ono H, Ohishi H, Benno Y. Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Curr Microbiol 2002; 44:212-5.
31. Matsumoto M, Benno Y. Anti-inflammatory and antimutagenic activity of polyamines produced by Bifidobacterium lactis LKM512. Curr Top Neutraceutical Res 2004; 2:219-26.
32. Matsumoto M, Ohishi H, Benno Y. Impact of LKM512 yogurt on improvement of intestinal environment of the elderly. FEMS Immunol Med Microbiol 2001; 31:181-6.
33. Matsumoto M, Benno Y. Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects. Mutat Res Fund Mol Mechan Mutagenesis 2004; 568:147-53.
34. Furue M, Furukawa M, Hide M, Takehara K. Guidelines for therapy for atopic dermatitis 2004. Jpn J Dermatol 2004; 114:135-42 (in Japanese with English summary).
35. Matsuki T, Watanabe K, Fujimoto J et al. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 2004; 70:167-73.
36. Lane DJ. 16S/23S rRNA sequence. In: Stackebrandt E, Goodfellow M, eds. Nucleic acid techniques in bacterial systematics. New York: John Wiley & Sons, 1991; 115-75.
37. Hayashi H, Sakamoto M, Benno Y. Evaluation of three different forward primers by terminal restriction fragment length polymorphism analysis for determination of fecal Bifidobacterium spp. in healthy subjects. Microbiol Immunol 2004; 48:1-6.
38. Matsumoto M, Sakamoto M, Hayashi H, Benno Y. Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota. J Microbiol Methods 2005; 61:305-19.
39. Sakamoto M, Hayashi H, Benno Y. Terminal restriction fragment length polymorphism analysis for human fecal microbiota and its application for analysis of complex bifidobacterial communities. Microbiol Immunol 2003; 47:133-42.
40. Kobashi K, Akao T, Hattori M, Namba T. Metabolism of drugs by intestinal bacteria. Bifidobacteria Microflora 1992; 11:9-23.
41. Ishihara M, Homma M, Kuno E, Watanabe M, Kohda Y. Combination use of Kampo-medicines and drugs affecting intestinal bacterial flora. Yakugaku Zasshi 2002; 122:695-701 (in Japanese with English summary).
42. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004; 145:612-6.
43. Capano G, Bloch KJ, Schiffrin EJ, Dascoli JA, Israel EJ, Harmatz PR. Influence of the polyamine, spermidine, on intestinal maturation and dietary antigen uptake in the neonatal rat. J Pediatr Gastroenterol Nutr 1994; 19:34-42.
44. Peulen O, Dewe W, Dandrifosse G, Henrotay I, Romain N. The relationship between spermine content of human milk during the first postnatal month and allergy in children. Public Health Nutr 1998; 1:181-4.
45. Matsumoto M, Kakizoe K, Benno Y. Comparison of fecal microbiota and polyamine concentration in adult patients with intractable atopic dermatitis and healthy adults. Microbiol Immunol 2007 (in press).
46. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81:1031-64.
47. Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21:793-8.
48. Hague A, Singh B, Paraskeva C. Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology 1997; 112:1036-40.
49. Milovic V. Polyamines in the gut lumen: bioavailability and biodistribution. Eur J Gastroenterol Hepatol 2001; 13:1021-5.
50. Uda K, Tsujikawa T, Fujiyama Y, Bamba T. Rapid absorption of luminal polyamines in a rat small intestine ex vivo model. J Gastroenterol Hepatol 2003; 18:554-9.
51. Forget PP, Degraeuwe PLJ, Smeets C, Deutz NEP. Fasting gastric fluid and fecal polyamine concentrations in premature infants. J Pediatr Gastroenterol Nutr 1997; 24:389-92.
52. Noack J, Kleesen B, Proll J, Dongowski G, Blaut M. Dietary guar gum and pectin stimulate intestinal microbial polyamine synthesis in rats. J Nutr 1998; 128:1385-91.
53. Matsumoto M, Tadenuma T, Nakamura K et al. Effect of Bifidobacterium lactis LKM 512 yoghurt on fecal microflora in middle to old aged persons. Microbial Ecol Health Dis 2000; 12:77-80.
54. Matsumoto M, Benno Y. The relationship between intestinal polyamines concentration and microbiota in humans: a pilot study. eds. Probiotics symposium '06.Tokyo, Japan (in Japanese): 2006: Abstract p. 7.
55. Scardovi V. Genus Bifidobacterium Orla-Jansen 1924, 472. In: Sneath PHA, Mair NS, Sharpe ME, Holt JG, eds. Bergey's manual of systematic bacteriology. Baltimore: Williams & Wilkins, 1986; 1418-34.
56. Matsumoto M, Benno Y. Consumption of probiotic yogurt containing Bifidobacterium animalis subsp. lactis LKM512 produces anti-inflammatory metabolites in the gut. Biosci Biotech Biochem 2006; 70:1287-92.
57. Seiler N, Atanassov CL. The natural polyamines and the immune system. Prog Drug Res 1994; 43:87-141.